EBV EBNA-1 Activators belong to a chemical class of compounds involved in the modulation of Epstein-Barr virus (EBV) and its associated protein, Epstein-Barr Nuclear Antigen 1 (EBNA-1). EBV is a herpesvirus that infects and establishes lifelong latency in human B lymphocytes. It is known to be associated with various diseases, including infectious mononucleosis and several types of lymphomas and carcinomas. EBNA-1 is one of the key viral proteins expressed during EBV infection and is essential for the replication and maintenance of the viral episome within host cells. It plays a crucial role in viral genome replication, transcriptional regulation, and immune evasion. Understanding the regulation of EBNA-1 and its interactions with host cellular components is essential for unraveling the biology of EBV.
The mechanism of action of EBV EBNA-1 Activators typically involves their interaction with EBNA-1, influencing its functions, protein-protein interactions, or its interactions with viral and host DNA. By modulating EBNA-1 activity, these activators impact the lifecycle of EBV, its ability to maintain latency within host cells, and its interactions with the host immune system. Research into EBV EBNA-1 Activators provides valuable insights into the complex interplay between viral proteins and host cellular machinery, shedding light on the molecular mechanisms underlying EBV infection and persistence within the human host.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid, another histone deacetylase inhibitor, is likely to affect EBNA-1 expression by modifying the chromatin structure and thus gene expression. |